Axiom Investors’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09M | Buy |
39,676
+4,834
| +14% | +$620K | 0.04% | 98 |
|
|
2025
Q1 | $3.08M | Sell |
34,842
-9,062
| -21% | -$802K | 0.03% | 112 |
|
|
2024
Q4 | $3.83M | Sell |
43,904
-1,920
| -4% | -$167K | 0.03% | 114 |
|
|
2024
Q3 | $4.24M | Sell |
45,824
-4,076
| -8% | -$377K | 0.04% | 110 |
|
|
2024
Q2 | $5.38M | Buy |
49,900
+5,630
| +13% | +$607K | 0.05% | 105 |
|
|
2024
Q1 | $4.2M | Buy |
44,270
+20,288
| +85% | +$1.92M | 0.04% | 112 |
|
|
2023
Q4 | $2.21M | Buy |
+23,982
| New | +$2.21M | 0.02% | 119 |
|
|
2019
Q4 | – | Sell |
-10,439
| Closed | -$767K | – | 119 |
|
|
2019
Q3 | $767K | Sell |
10,439
-9,888
| -49% | -$727K | 0.02% | 116 |
|
|
2019
Q2 | $1.92M | Buy |
20,327
+4,130
| +25% | +$389K | 0.05% | 100 |
|
|
2019
Q1 | $1.3M | Sell |
16,197
-2,735
| -14% | -$219K | 0.04% | 113 |
|
|
2018
Q4 | $1.02M | Sell |
18,932
-969
| -5% | -$52.3K | 0.04% | 119 |
|
|
2018
Q3 | $1.55M | Sell |
19,901
-1,515
| -7% | -$118K | 0.04% | 127 |
|
|
2018
Q2 | $1.36M | Buy |
+21,416
| New | +$1.36M | 0.04% | 135 |
|